enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. National Vaccine Injury Compensation Program - Wikipedia

   en.wikipedia.org/wiki/National_Vaccine_Injury...

   The VICP was adopted in response to concerns over the pertussis portion of the DPT vaccine. [1] Several U.S. lawsuits against vaccine makers won substantial awards. Most makers ceased production, and the last remaining major manufacturer threatened to do so. [1] The VICP uses a no-fault system for resolving vaccine injury claims. [1]

3. Silent Majority Foundation files lawsuit over AGO workers let ...

   www.aol.com/news/silent-majority-foundation...

   In August 2021, Gov. Jay Inslee issued a directive mandating that all state employees be vaccinated against COVID-19 as a condition of employment. On May 11, 2023, the governor rescinded that ...

4. Asbestos and the law (United States) - Wikipedia

   en.wikipedia.org/wiki/Asbestos_and_the_law...

   Asbestos litigation is the longest, most expensive mass tort in U.S. history, involving more than 8,000 defendants and 700,000 claimants. [1] By the early 1990s, "more than half of the 25 largest asbestos manufacturers in the US, including Amatex, Carey-Canada, Celotex, Eagle-Picher, Forty-Eight Insulations, Manville Corporation, National Gypsum, Standard Insulation, Unarco, and UNR Industries ...

5. Profitable companies are dodging asbestos lawsuits. A ... - AOL

   www.aol.com/profitable-companies-dodging...

   Charlotte’s bankruptcy court has become a national haven for multibillion-dollar companies facing lawsuits from people sickened by asbestos. Profitable companies are dodging asbestos lawsuits. A ...

6. Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine

   www.aol.com/news/pfizer-resolves-promosome...

   The lawsuits said that Promosome discussed its technology with representatives from Moderna and BioNTech between 2013 and 2016. Promosome had asked the court for a share of royalties from the shots.

7. Special Report: Countries, companies risk billions in race ...

   www.aol.com/news/special-report-countries...

   Historically, just 6% of vaccine candidates end up making it to market, often after a years-long process that doesn’t draw big investments until testing shows a product is likely to work.